Teleflex | TFX - Equity Capital And Reserves


Teleflex reported $3.12B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Align Technology USD 4.05B 91.69M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
AtriCure USD 491.94M 15.43M Dec/2025
Avanos Medical USD 778.2M 200K Dec/2025
Baxter International USD 6.04B 86M Mar/2026
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 25.86B 1.63B Mar/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.96B 210.9M Mar/2026
Edwards Lifesciences USD 10.34B 132.6M Dec/2025
General Electric Aerospace USD 18.06B 841M Mar/2026
Globus Medical USD 4.57B 174.42M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.47B 349.5M Mar/2026
J&J USD 81.19B 358M Mar/2026
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.63B 42.42M Mar/2026
Orthofix International USD 450.04M 7.55M Dec/2025
ResMed USD 6.49B 171.03M Mar/2026
Steris USD 7.15B 145.4M Dec/2025
Stryker USD 22.42B 635M Dec/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026